Why did this investor plough a million into this ASX company at triple its market price?
Brought to you by CPS Capital
Matt Birney - Thanks Tim
Matt Birney - OK so Besra Gold doubled this week after its major shareholder paid triple the market price to get more stock in the Malaysian-focused gold explorer.
Matt Birney - Its shares finished last week at 3.1 cents and hit 6.5 cents this week after that shareholder ploughed another million in at 9 cents.
Matt Birney - Biotechnology company Actinogen Medical broke out of its trading halt to hit 16 cents this week – up from 9.6 cents after tabling a positive clinical trial result for its Alzheimer’s treatment.
Matt Birney - Tech company Netlinkz ran 47 per cent to hit 2.8 cents – up from 1.9 cents last week… on no news at all interestingly – that is unless you consider Investment Bank Credit Suisse picking up 5 per cent of the company to be news.
Matt Birney - And finally, a couple of weeks ago I spoke about Dundas Minerals hiking 267 per cent to hit 77 cents a share that week– well, if you thought they’d puffed out at 77 cents you’d be wrong.
Matt Birney - Its stock hit $1.55 this week after drilling through 358m of nickel/copper sulphides – that is before hitting the floor again at 50 cents after the previous assays didn’t hit the mark.